Valuation: Camurus AB

Market Cap 36.09B 3.79B 3.25B 3.05B 2.79B 5.26B 361B 5.28B 13.99B 182B 14.21B 13.91B 603B P/E 2026 *
37.7x
P/E 2027 * 24.4x
Enterprise Value 31.58B 3.31B 2.84B 2.67B 2.44B 4.6B 316B 4.62B 12.24B 159B 12.44B 12.17B 528B EV / Sales 2026 *
11.1x
EV / Sales 2027 * 8.08x
Free-Float
66.89%
Yield 2026 *
-
Yield 2027 * -
1 day-1.38%
1 week-3.88%
Current month-1.78%
1 month-1.62%
3 months+15.74%
6 months+19.86%
Current year-1.54%
1 week 605
Extreme 605
644.5
1 month 586.5
Extreme 586.5
644.5
Current year 430.8
Extreme 430.8
710
1 year 430.8
Extreme 430.8
754.5
3 years 282
Extreme 282
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 2002-12-31
Director of Finance/CFO 57 2025-06-30
Chief Tech/Sci/R&D Officer 58 2024-12-31
Director TitleAgeSince
Director/Board Member 63 2001-12-31
Chairman 77 2014-12-31
Director/Board Member 61 2020-05-06
Date Insider Type Main position Quantity % Market Cap.
8/7/26 Sell

Executive/Senior Manager

-5,800 0.0096%
2/27/26 Sell

Chief Executive Officer

55,550 0.0928%
2/27/26 Sell

Chief Executive Officer

1,500 0.0025%
Change 5-day change 1-year change 3-year change Capi.($)
-1.38%-3.88%-13.67%+107.00% 3.86B
-3.59%-7.10%+61.60%+114.83% 1,100B
-1.15%-1.25%+52.98%+62.41% 658B
-1.09%-1.15%+26.18%+79.22% 470B
-1.47%+0.24%+42.09%+42.09% 372B
-0.90%+0.05%+25.57%+41.75% 304B
-1.94%+1.53%+3.05%+13.24% 264B
-0.43%-0.46%+52.06%+71.75% 239B
-0.93%+1.84%-13.11%-52.28% 213B
-0.46%+0.33%+29.05%+92.67% 184B
Average -1.33%-0.02%+26.58%+57.27% 380.67B
Weighted average by Cap. -1.82%-1.58%+40.48%+68.28%

Financials

2026 *2027 *
Net sales 2.86B 300M 257M 241M 220M 416M 28.58B 418M 1.11B 14.42B 1.13B 1.1B 47.75B 3.75B 393M 337M 317M 289M 546M 37.49B 549M 1.45B 18.92B 1.48B 1.44B 62.65B
Net income 949M 99.55M 85.44M 80.2M 73.25M 138M 9.49B 139M 368M 4.79B 374M 366M 15.87B 1.45B 152M 131M 123M 112M 212M 14.53B 213M 563M 7.33B 572M 560M 24.28B
Net Debt -4.52B -474M -407M -382M -349M -658M -45.19B -661M -1.75B -22.8B -1.78B -1.74B -75.51B -5.81B -609M -523M -491M -448M -846M -58.1B -850M -2.25B -29.31B -2.29B -2.24B -97.07B
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
316
Date Price Change Volume
26-08-26 SEK 606.50 -1.38% 75,668
26-08-25 SEK 615.00 +0.90% 63,872
26-08-24 SEK 609.50 -2.40% 400,761
26-08-21 SEK 624.50 -0.87% 47,395
26-08-20 SEK 630.00 -0.16% 61,987
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
606.50SEK
Average target price
793.00SEK
Spread / Average Target
+30.75%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAMX Stock